FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040978781> ?p ?o ?g. }

• W2040978781 endingPage "1096" @default.
• W2040978781 startingPage "1092" @default.
• W2040978781 abstract "We sought to compare the effect of manidipine versus hydrochlorothiazide (HCTZ) in addition to candesartan on the urinary albumin excretion rate (UAER) in hypertensive patients with type II diabetes and microalbuminuria. After a 2-week washout and run-in period, and 8-week monotherapy with candesartan 16 mg every day, 174 microalbuminuric diabetic hypertensive patients with uncontrolled blood pressure (BP) (>130/80 mm Hg) were randomized to addition of manidipine 10 mg every day (n = 87) or HCTZ 12.5 mg every day (n = 87) for 24 weeks, with a titration after 4 weeks (manidipine or HCTZ dose-doubling) in nonresponder patients. Blood pressure, UAER, creatinine clearance, serum electrolytes, fasting plasma glycemia, and glycosylated hemoglobin were evaluated at baseline (end of run-in period), after candesartan monotherapy, and at the end of the combination treatment period. Both combinations produced greater systolic BP/diastolic BP reduction than candesartan monotherapy (−28/21 mm Hg versus −16/11 mm Hg and −28/20 mm Hg versus −15/11 mm Hg, respectively; all P < .05 versus monotherapy), with no significant difference between the two combinations. The addition of manidipine produced a greater reduction in UAER than candesartan monotherapy (−55.4 mg/24 h v −36.1 mg/24 h, P < .05), whereas the addition of HCTZ did not significantly modify UAER; the difference between the two combinations was statistically significant (P < .05). Similarly, the percentage of patients moving to a normoalbuminuric state (UAER <30 mg/24 h) was increased by the addition of manidipine to candesartan (from 35% to 64%, P < .05), but not by the addition of HCTZ (from 34% to 39%, NS), with a statistical difference between the two combinations (P < .05). These findings show that, despite equivalent reduction in BP, the addition of manidipine to candesartan further reduced the UAER, whereas the addition of HCTZ did not modify the UAER. This suggests that the antiproteinuric effect of manidipine is partially independent of BP reduction, and is attributable to mechanisms different from those mediated by angiotensin receptor blockade. Am J Hypertens 2007;20: 1092–1096 © 2007 American Journal of Hypertension, Ltd." @default.
• W2040978781 created "2016-06-24" @default.
• W2040978781 creator A5001663190 @default.
• W2040978781 creator A5024568777 @default.
• W2040978781 creator A5031435734 @default.
• W2040978781 creator A5038668185 @default.
• W2040978781 creator A5039188583 @default.
• W2040978781 creator A5059529605 @default.
• W2040978781 creator A5085524838 @default.
• W2040978781 date "2007-10-01" @default.
• W2040978781 modified "2023-10-16" @default.
• W2040978781 title "Addition of Manidipine Improves the Antiproteinuric Effect of Candesartan in Hypertensive Patients With Type II Diabetes and Microalbuminuria" @default.
• W2040978781 cites W1710832400 @default.
• W2040978781 cites W1824174105 @default.
• W2040978781 cites W1929592694 @default.
• W2040978781 cites W1964920299 @default.
• W2040978781 cites W2028626467 @default.
• W2040978781 cites W2036237044 @default.
• W2040978781 cites W2045975885 @default.
• W2040978781 cites W2049397775 @default.
• W2040978781 cites W2056976690 @default.
• W2040978781 cites W2061480158 @default.
• W2040978781 cites W2070687566 @default.
• W2040978781 cites W2074921868 @default.
• W2040978781 cites W2079985008 @default.
• W2040978781 cites W2101276501 @default.
• W2040978781 cites W2107446775 @default.
• W2040978781 cites W2114646524 @default.
• W2040978781 cites W2118286022 @default.
• W2040978781 cites W2118454019 @default.
• W2040978781 cites W2118492008 @default.
• W2040978781 cites W2136898798 @default.
• W2040978781 cites W2141577997 @default.
• W2040978781 cites W2143900195 @default.
• W2040978781 cites W2144489880 @default.
• W2040978781 cites W2153701973 @default.
• W2040978781 cites W2156121263 @default.
• W2040978781 cites W2396051933 @default.
• W2040978781 cites W2401564367 @default.
• W2040978781 cites W2402878368 @default.
• W2040978781 cites W2003670762 @default.
• W2040978781 doi "https://doi.org/10.1016/j.amjhyper.2007.05.012" @default.
• W2040978781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17903693" @default.
• W2040978781 hasPublicationYear "2007" @default.
• W2040978781 type Work @default.
• W2040978781 sameAs 2040978781 @default.
• W2040978781 citedByCount "28" @default.
• W2040978781 countsByYear W20409787812012 @default.
• W2040978781 countsByYear W20409787812013 @default.
• W2040978781 countsByYear W20409787812016 @default.
• W2040978781 countsByYear W20409787812017 @default.
• W2040978781 countsByYear W20409787812018 @default.
• W2040978781 countsByYear W20409787812019 @default.
• W2040978781 countsByYear W20409787812020 @default.
• W2040978781 countsByYear W20409787812023 @default.
• W2040978781 crossrefType "journal-article" @default.
• W2040978781 hasAuthorship W2040978781A5001663190 @default.
• W2040978781 hasAuthorship W2040978781A5024568777 @default.
• W2040978781 hasAuthorship W2040978781A5031435734 @default.
• W2040978781 hasAuthorship W2040978781A5038668185 @default.
• W2040978781 hasAuthorship W2040978781A5039188583 @default.
• W2040978781 hasAuthorship W2040978781A5059529605 @default.
• W2040978781 hasAuthorship W2040978781A5085524838 @default.
• W2040978781 hasBestOaLocation W20409787811 @default.
• W2040978781 hasConcept C126322002 @default.
• W2040978781 hasConcept C126894567 @default.
• W2040978781 hasConcept C134018914 @default.
• W2040978781 hasConcept C2776174234 @default.
• W2040978781 hasConcept C2777180221 @default.
• W2040978781 hasConcept C2777538456 @default.
• W2040978781 hasConcept C2780036600 @default.
• W2040978781 hasConcept C2780361556 @default.
• W2040978781 hasConcept C2781203188 @default.
• W2040978781 hasConcept C2908929049 @default.
• W2040978781 hasConcept C555293320 @default.
• W2040978781 hasConcept C71924100 @default.
• W2040978781 hasConcept C84393581 @default.
• W2040978781 hasConceptScore W2040978781C126322002 @default.
• W2040978781 hasConceptScore W2040978781C126894567 @default.
• W2040978781 hasConceptScore W2040978781C134018914 @default.
• W2040978781 hasConceptScore W2040978781C2776174234 @default.
• W2040978781 hasConceptScore W2040978781C2777180221 @default.
• W2040978781 hasConceptScore W2040978781C2777538456 @default.
• W2040978781 hasConceptScore W2040978781C2780036600 @default.
• W2040978781 hasConceptScore W2040978781C2780361556 @default.
• W2040978781 hasConceptScore W2040978781C2781203188 @default.
• W2040978781 hasConceptScore W2040978781C2908929049 @default.
• W2040978781 hasConceptScore W2040978781C555293320 @default.
• W2040978781 hasConceptScore W2040978781C71924100 @default.
• W2040978781 hasConceptScore W2040978781C84393581 @default.
• W2040978781 hasIssue "10" @default.
• W2040978781 hasLocation W20409787811 @default.
• W2040978781 hasLocation W20409787812 @default.
• W2040978781 hasOpenAccess W2040978781 @default.
• W2040978781 hasPrimaryLocation W20409787811 @default.
• W2040978781 hasRelatedWork W1643020507 @default.
• W2040978781 hasRelatedWork W177762941 @default.
• W2040978781 hasRelatedWork W2011930145 @default.

• next